Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

Rachel Reeves’s tax raid pulled in £300m less than expected during its first two months of operation, the Office for Budget ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

London’s FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and ...

AstraZeneca has unveiled plans to invest around ... The C$820 million investment revolves around a new, larger office facility in the Greater Toronto area and will see AZ's Canadian headcount ...

Since BlackRock’s appointment as Investment Manager on 1 April 2012. 4 Further details are given in the Glossary in the Half Yearly Financial Report. Equity market investors sought alternative assets ...

AstraZeneca's plan to invest £450 million ... After Reeves came into office she carried out an audit of public spending, claiming that she had inherited a £22 billion “black hole” in ...

Though threatened, new drug discoveries are still an American advantage A decade ago, China had just a few hundred pharmaceutical drugs actively in development. Today, China has thousands of drugs in ...

Interest rate speculation and Middle East uncertainty today held back European markets during a lacklustre session for the ...